XOSPATA® 40 MG COM REV CT BL AL AL X 84
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1771700100015 -
GGREM
540320080003707 -
Código de barras
7899337001063
O que a fonte publica
- Detentor do registro
- ASTELLAS FARMA BRASIL IMPORTAÇÃO E DISTRIBUIÇÃO DE MEDICAMENTOS LTDA.
- Princípios ativos
- HEMIFUMARATO DE GILTERITINIBE
- Embalagem
- 40 MG COM REV CT BL AL AL X 84
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "XOSPATA® 40 MG COM REV CT BL AL AL X 84",
"holder": "ASTELLAS FARMA BRASIL IMPORTAÇÃO E DISTRIBUIÇÃO DE MEDICAMENTOS LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7899337001063"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "540320080003707",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "07.768.134/0001-04",
"priceRegime": "Regulado",
"productName": "XOSPATA®",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "40 MG COM REV CT BL AL AL X 84",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "117393.82",
"icms-12": "133402.11",
"icms-17": "141438.30",
"icms-18": "143163.17",
"icms-19": "144930.65",
"icms-20": "146742.28",
"icms-21": "148599.80",
"icms-22": "150504.86",
"icms-23": "152459.47",
"icms-17.5": "142295.51",
"icms-19.5": "145830.83",
"icms-20.5": "147665.23",
"icms-22.5": "151475.95",
"icms-12-alc": "119109.06",
"icms-17-alc": "126284.17",
"icms-18-alc": "127824.26",
"icms-19-alc": "129402.27",
"icms-20-alc": "131019.84",
"icms-21-alc": "132678.38",
"icms-22-alc": "134379.30",
"icms-23-alc": "136124.47",
"withoutTaxes": "104815.89",
"icms-17.5-alc": "127049.58",
"icms-19.5-alc": "130206.06",
"icms-20.5-alc": "131843.83",
"icms-22.5-alc": "135246.25"
},
"pisCofinsList": "Negativa",
"substanceText": "HEMIFUMARATO DE GILTERITINIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "157479.63",
"icms-12": "178954.18",
"icms-17": "189734.44",
"icms-18": "192048.30",
"icms-19": "194419.31",
"icms-20": "196849.54",
"icms-21": "199341.34",
"icms-22": "201896.91",
"icms-23": "204518.95",
"icms-17.5": "190884.36",
"icms-19.5": "195626.87",
"icms-20.5": "198087.65",
"icms-22.5": "203199.59",
"icms-12-alc": "164661.29",
"icms-17-alc": "174580.46",
"icms-18-alc": "176709.54",
"icms-19-alc": "178891.05",
"icms-20-alc": "181127.24",
"icms-21-alc": "183420.08",
"icms-22-alc": "185771.50",
"icms-23-alc": "188184.09",
"withoutTaxes": "144901.82",
"icms-17.5-alc": "175638.59",
"icms-19.5-alc": "180002.24",
"icms-20.5-alc": "182266.36",
"icms-22.5-alc": "186970.01"
},
"invalidBarcodes": [],
"activeSubstances": [
"HEMIFUMARATO DE GILTERITINIBE"
],
"therapeuticClass": "L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1771700100015",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H9",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:540320080003707"